Search - tctmd.com

Displaying 141 - 160 of 700

Sort: Relevancy | Date

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

News Conference News ACC 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

March 17, 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

March 10, 2017

CoreValve™ Evolut™ R Tavi System Intermediate Risk Indication

Presentation JIM 2017

CoreValve™ Evolut™ R Tavi System Intermediate Risk Indication

Presenter: Alberto Cremonesi

February 10, 2017

Early Clinical Outcomes with Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

News Daily News

Early Clinical Outcomes With Evolut R Reassure, Suggest Improvements Over First-Gen CoreValve

Michael O'Riordan

February 09, 2017

TAVR Boosts Health Status in Most Patients, But Many Still Suffer Post-Procedure

News Daily News

TAVR Boosts Health Status in Most Patients, but Many Still Suffer Postprocedure

February 06, 2017

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

News Conference News ISET 2017

Forging Into the Future: Debating the Merits of TAVR in Younger, Futile, and Lower-Risk Patients

February 06, 2017

Clinical Outcomes With Subclavian TAVR as Good as With Transfemoral Access, Small Analysis Shows

News Daily News

Clinical Outcomes With Subclavian TAVR as Good as With Transfemoral Access, Small Analysis Shows

Michael O'Riordan

January 26, 2017

News Daily News

Prosthesis-Patient Mismatch After Aortic Valve Replacement Declining but Tied to Poorer Survival

January 25, 2017

News Features

The Prickly Problem of Permanent Pacing After TAVR: One Hospital Pitches a Protocol

Michael O'Riordan

January 24, 2017

News Industry News

Medtronic Announces CE Mark and European Launch of Recaptureable TAVI System Now Available for Severe Aortic Stenosis Patients with Large Anatomies

January 17, 2017

Conduction Problems Requiring Permanent Pacemakers Continue to Vex TAVR Field

News Daily News

Conduction Problems Requiring Permanent Pacemakers Continue to Vex TAVR Field

November 08, 2016

The ELECT Trial: A Randomized Evaluation of Periprosthetic Regurgitation After TAVI With Sapien 3 or CoreValve Using Mulit-Modality Imaging

Presentation TCT 2016

The ELECT Trial: A Randomized Evaluation of Periprosthetic Regurgitation After TAVI With Sapien 3 or CoreValve Using Mulit-Modality Imaging

Presenter: Neil E. Moat, John G. Webb, Pieter R. Stella

October 31, 2016

TCT 1515: The Dance of the Corevalve

Presentation TCT 2016

TCT 1515: The Dance of the Corevalve

Presenter: Jean-Claude Laborde, Thomas Walther, Smriti Saraf

October 31, 2016

TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program

Presentation TCT 2016

TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program

Presenter: Charles J. Davidson, Michael J. Reardon, James B. Hermiller Jr.

October 31, 2016

News Daily News

开心手术后需要 ICD 和起搏器：系列研究提供了指导

October 21, 2016

News Daily News

Necesidad de DCI y Marcapasos Post-Cirugía Cardíaca Abierta: Una Serie Ofrece un Punto de Referencia

October 21, 2016

News Daily News

ICD and Pacemaker Needs After Open Heart Surgery: Series Provides a Benchmark

October 21, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2016

September 30, 2016

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2016

September 30, 2016

News Conference News PCR London Valves 2016

Cerebral Protection in TAVR: New Insights, New Questions as First Device Seeks FDA Clearance

September 22, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.